{"id":"W1549596568","doi":"10.1002/pros.22965","title":"Safety of enzalutamide in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel: Expanded access in North America","year":2015,"lang":"en","type":"article","venue":"The Prostate","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Western University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Université de Montréal; University Health Network","funders":"National Cancer Institute; Astellas Pharma; Exelixis; Sanofi; Pfizer; Amgen","keywords":"Enzalutamide; Prostate cancer; Docetaxel; Cabazitaxel; Medicine; Adverse effect; Internal medicine; Oncology; Population; Discontinuation; Expanded access; Cancer; Urology; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003043982,0.0002894882,0.0005762826,0.0002259484,0.00005824877,0.00004380075,0.0001962386,0.00002702464,0.00002288109],"category_scores_gemma":[0.00003955518,0.0001447443,0.00003532546,0.001301917,0.0003127448,0.0003123418,0.00006501941,0.0002661686,0.000003984972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004244472,"about_ca_system_score_gemma":0.0009134173,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003830928,"about_ca_topic_score_gemma":0.009563745,"domain_scores_codex":[0.9977,0.0001858716,0.0005109344,0.0003739491,0.0006685727,0.0005606693],"domain_scores_gemma":[0.9986651,0.00006356933,0.0002698837,0.0003966537,0.0004094714,0.0001953073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03709252,0.0006147065,0.9473115,0.000222733,0.000214777,0.0001274247,0.007405311,0.001866277,0.00009542697,0.000002905,0.000038906,0.005007531],"study_design_scores_gemma":[0.02784675,0.003252244,0.9643496,0.0006385463,0.0002244246,0.000006442516,0.000971439,0.0001820655,0.002019414,0.00004022715,0.0002061113,0.000262704],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941894,0.0006373388,0.000006233629,0.0006328119,0.00001559183,0.003996219,0.0002054535,0.00003135717,0.0002856111],"genre_scores_gemma":[0.9976868,0.0004813692,0.0001772275,0.00007624473,0.00000950147,0.000583833,0.0002685422,0.00004509842,0.0006714052],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01703815,"threshold_uncertainty_score":0.59025,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03335284117947412,"score_gpt":0.3166108667720986,"score_spread":0.2832580255926245,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}